Table 2.
Comparison of the clinical characteristics of Group I and Group II#.
| Group I | Group II | P-value | |
|---|---|---|---|
| Sex (%) | 44.4% | 40.8% | 1.00 |
| Consanguinity (% present) | 44.4% | 18.4% | 0.07 |
| Birthweight (g)* | 3031.11 ± 617.61 | 3171.05 ± 528.12 | 0.62 |
| Time of presentation (days)* | 63.67 ± 32.68 | 40.08 ± 21.53 | 0.01 |
| IRT-1 (ng/mL)* | 168.79 ± 70.54 | 112.58 ± 30.2 | 0.001 |
| IRT-2 (ng/mL)* | 163.93 ± 86.95 | 87.57 ± 23.89 | <0.001 |
| Gestational week at birth (weeks)* | 36.56 ± 3.32 | 38.84 ± 1.69 | 0.007 |
*Values are stated as mean ± SD.
#Group I: Patients diagnosed with CF as a result of further tests; Group II: those not diagnosed with CF.